epigallocatechin gallate has been researched along with Adrenal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, T; He, C; Wang, D; Wang, R; Wu, M; Zhou, J | 1 |
| Chen, HJ; Chiu, YJ; Chung, JG; Huang, LJ; Huang, WW; Kuo, SC; Lai, KC; Lin, KL; Wu, PP; Yang, JS | 1 |
2 other study(ies) available for epigallocatechin gallate and Adrenal Cancer
| Article | Year |
|---|---|
PLAGL1 Gene Demethylation Induced by Epigallocatechin Gallate Promotes Pheochromocytoma Cell Apoptosis Via Wnt/β-catenin Signaling Pathway.
Topics: Adrenal Gland Neoplasms; Animals; Apoptosis; beta Catenin; Catechin; Cell Cycle Proteins; Demethylation; Genes, Tumor Suppressor; Humans; PC12 Cells; Pheochromocytoma; Rats; RNA, Messenger; Transcription Factors; Tumor Suppressor Proteins; Wnt Signaling Pathway | 2022 |
(-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway.
Topics: Adrenal Gland Neoplasms; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Calcium; Caspases; Catechin; Endoplasmic Reticulum Chaperone BiP; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Protease Inhibitors; Tumor Cells, Cultured | 2009 |